Bridging CGRP Antibodies With Gepants: Innovative Combined Migraine Approach
Novel approach combining CGRP monoclonal antibodies with gepant small molecules offers innovative migraine management strategy using both drug classes synergistically.
Quick Facts
What This Study Found
Novel approach combining CGRP monoclonal antibodies with gepant small molecules offers innovative migraine management strategy using both drug classes synergistically.
Key Numbers
24-month follow-up across 16 clinic visits evaluating combined CGRP mAb and gepant therapy.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide therapeutic knowledge.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Comparison to evidence?
- ?Next research?
Trust & Context
- Key Stat:
- Key finding Novel approach combining CGRP monoclonal antibodies with gepant small molecules offers innovative mi
- Evidence Grade:
- Based on study design.
- Study Age:
- Published in 2025.
- Original Title:
- Bridging CGRP mAbs with Gepants: An innovative approach to address the wearing-off phenomenon.
- Published In:
- Clinical neurology and neurosurgery, 258, 109183 (2025)
- Authors:
- Alsaadi, Taoufik(3), Adel, Fatema, Alsaffarini, Kareem(2), El Jadam, Caline, Alkhateri, Athra, Pagdato, Beverly, Suliman, Reem
- Database ID:
- RPEP-09904
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Novel approach combining CGRP monoclonal antibodies with gepant small molecules offers innovative migraine management strategy using both drug classes synergistically.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09904APA
Alsaadi, Taoufik; Adel, Fatema; Alsaffarini, Kareem; El Jadam, Caline; Alkhateri, Athra; Pagdato, Beverly; Suliman, Reem. (2025). Bridging CGRP mAbs with Gepants: An innovative approach to address the wearing-off phenomenon.. Clinical neurology and neurosurgery, 258, 109183. https://doi.org/10.1016/j.clineuro.2025.109183
MLA
Alsaadi, Taoufik, et al. "Bridging CGRP mAbs with Gepants: An innovative approach to address the wearing-off phenomenon.." Clinical neurology and neurosurgery, 2025. https://doi.org/10.1016/j.clineuro.2025.109183
RethinkPeptides
RethinkPeptides Research Database. "Bridging CGRP mAbs with Gepants: An innovative approach to a..." RPEP-09904. Retrieved from https://rethinkpeptides.com/research/alsaadi-2025-bridging-cgrp-mabs-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.